Adynxx Raises $16M

San Francisco-based Adynxx, a developer of therapeutics for treating chronic pain, said this week that it has raised $16M in a Series B funding round

The story you have requested is only available to paid members of the web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.